Form 8-K - Current report:
SEC Accession No. 0000950123-05-013750
Filing Date
2005-11-16
Accepted
2005-11-16 16:37:24
Documents
4
Period of Report
2005-11-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y14869e8vk.htm 8-K 24451
2 EX-10.1: STOCK INCENTIVE PLAN FOR PRE-MERGER EMPLOYEES y14869exv10w1.htm EX-10.1 34257
3 EX-10.2: STOCK PLAN FOR ASSUMED OPTIONS OF PRE-MERGER EMPLOYEES y14869exv10w2.htm EX-10.2 69376
4 EX-99.1: PRESS RELEASE y14869exv99w1.htm EX-99.1 6779
  Complete submission text file 0000950123-05-013750.txt   136589
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 051210226
SIC: 2835 In Vitro & In Vivo Diagnostic Substances